Literature DB >> 10399848

Development of an optimal bacterial medium based on the growth inhibition assay with Vibrio fischeri.

G Gellert1, A Stommel, A B Trujillano.   

Abstract

Chronic toxicity level of chemicals to bacteria can depend on composition and concentration of medium ingredients. This was demonstrated by means of a growth rate inhibition test with the marine bacterium V. fischeri. In a minimal medium (following the validity criterion of achieving a least cell multiplication rate) containing only yeast extract as organic nutrient component, V. fischeri was to Cu2+ 11.9 times, to Hg2+ 3 times and to Zn2+ 2.8 times more sensitive than in the complete defined medium. Obviously yeast extract did not interfere greatly in the complexation mechanisms. The detection limits of the toxicity of Cd2+, 3,5-dichorophenol and nitrobenzene were not influenced by the substrate.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10399848     DOI: 10.1016/s0045-6535(99)00002-8

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  4 in total

1.  A novel antibacterial titania coating: metal ion toxicity and in vitro surface colonization.

Authors:  F Heidenau; W Mittelmeier; R Detsch; M Haenle; F Stenzel; G Ziegler; H Gollwitzer
Journal:  J Mater Sci Mater Med       Date:  2005-10       Impact factor: 3.896

2.  Inbuilt potential of YEM medium and its constituents to generate Ag/Ag₂O nanoparticles.

Authors:  G Yamal; P Sharmila; K S Rao; P Pardha-Saradhi
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

3.  A new short-term toxicity assay using Aspergillus awamori with recombinant aequorin gene.

Authors:  Olga Kozlova; Mark Zwinderman; Nick Christofi
Journal:  BMC Microbiol       Date:  2005-07-02       Impact factor: 3.605

4.  A biocompatible sol-gel derived titania coating for medical implants with antibacterial modification by copper integration.

Authors:  Hans Gollwitzer; Maximilian Haenle; Wolfram Mittelmeier; Frank Heidenau; Norbert Harrasser
Journal:  AMB Express       Date:  2018-02-19       Impact factor: 3.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.